OTCMKTS:SBMFF Sino Biopharmaceutical (SBMFF) Stock Price, News & Analysis → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free SBMFF Stock Alerts $0.31 0.00 (0.00%) (As of 05/1/2024 ET) Add Compare Share Share Today's Range$0.31▼$0.3150-Day Range$0.31▼$0.4252-Week Range$0.32▼$0.54VolumeN/AAverage Volume300 shsMarket Capitalization$5.93 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Get Sino Biopharmaceutical alerts: Email Address Ad MillPub😱 This phenomenon is smashing regular market gainsThanks to a little-known “Pathfinder” trading phenomenon… Traders have recently unlocked one of the most powerful idea-generation sources in the history of trading. At every single market open.Click here to save your seat and join the next LIVE workshop! About Sino Biopharmaceutical Stock (OTCMKTS:SBMFF)Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines comprising Qingkeshu tablets, Focus V capsules, Annike injection, and Anyue capsules; liver disease medicines, including Tianqing ganmei injection and Runzhong dispersible tablets; and respiratory system medicines, such as Tianqing suchang suspension for inhalation and Tianyun for injection. It also provides surgery/analgesia medicines comprising Debaian cataplasms and Gaisanchun soft capsules; and cardio-cerebral vascular medicines, including Yilunping and Kaina tablets. In addition, the company is involved in the long term investments; and healthcare and hospital business. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.Read More SBMFF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SBMFF Stock News HeadlinesApril 28, 2024 | americanbankingnews.comSino Biopharmaceutical (OTCMKTS:SBMFF) Hits New 52-Week Low at $0.31April 26, 2024 | americanbankingnews.comSino Biopharmaceutical Limited (OTCMKTS:SBMFF) Sees Large Increase in Short InterestMay 1, 2024 | MillPub (Ad)😱 This phenomenon is smashing regular market gainsThanks to a little-known “Pathfinder” trading phenomenon… Traders have recently unlocked one of the most powerful idea-generation sources in the history of trading. At every single market open.April 21, 2024 | americanbankingnews.comSino Biopharmaceutical (OTCMKTS:SBMFF) Sets New 1-Year Low at $0.32February 6, 2024 | reuters.comSino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mlnFebruary 6, 2024 | news.yahoo.comSino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 millionJanuary 30, 2024 | wsj.comSino Biopharmaceutical Ltd.December 29, 2023 | markets.businessinsider.comJefferies Keeps Their Buy Rating on Sino Biopharmaceutical (SBMFF)May 1, 2024 | MillPub (Ad)😱 This phenomenon is smashing regular market gainsThanks to a little-known “Pathfinder” trading phenomenon… Traders have recently unlocked one of the most powerful idea-generation sources in the history of trading. At every single market open.December 15, 2023 | bbc.co.ukBirmingham's Ahmad Al Sino jailed for relative's wedding row murderNovember 7, 2023 | finance.yahoo.comHong Kong Shares Turn Higher as Lower Oil Prices, Treasury Yields SupportOctober 4, 2023 | finance.yahoo.comInsights into Sino Biopharmaceutical Ltd's Dividend PerformanceSeptember 29, 2023 | uk.investing.comSino Logistics Corporation PCL (SINO)September 13, 2023 | jp.reuters.comSino Biopharmaceutical LtdJuly 17, 2023 | investing.comSino Biopharmaceutical Ltd ADR (SBHMY)May 30, 2023 | forbes.comSino-ForestMarch 12, 2023 | finance.yahoo.comSino Biopharmaceutical Limited (1177.HK)March 7, 2023 | msn.comSino Biopharm Wins CFIUS Approval for $161 Million F-Star DealJanuary 26, 2023 | finance.yahoo.cominvoX Pharma and F-star Therapeutics issue Joint StatementNovember 11, 2022 | seekingalpha.comF-star Therapeutics: At A Discount Of >30% To Takeover Offer, With CFIUS Approval On The HorizonAugust 28, 2022 | finance.yahoo.comChina's CanSinoBIO H1 revenue drops on weaker COVID shot demandJuly 18, 2022 | benzinga.comSino Biopharmaceutical (OTC:SBMFF), Short Interest ReportJuly 18, 2022 | benzinga.comSino Biopharmaceutical (OTC:SBMFF), Analyst Ratings, Price Targets, PredictionsJune 26, 2022 | seekingalpha.comWeek In Review: invoX, A Sino Biopharm Company, To Pay $161 Million To Acquire F-StarJune 23, 2022 | benzinga.comThe Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows PromiseJune 23, 2022 | marketwatch.comSino Biopharmaceutical Unit to Buy F-star Therapeutics for $161 Million >FSTXJune 23, 2022 | seekingalpha.comSino Biopharma to acquire F-star Therapeutics for $161MSee More Headlines Receive SBMFF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sino Biopharmaceutical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private households Sub-IndustryN/A Current SymbolOTCMKTS:SBMFF Previous SymbolNASDAQ:SBMFF CUSIPN/A CIK1604982 Webwww.sinobiopharm.com Phone852-2802-9886Fax852-2880-0847Employees25,806Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares18,813,870,000Free FloatN/AMarket Cap$5.93 billion OptionableNot Optionable Beta0.45 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMs. Y. Y. Tse (Age 32)Executive Chairwoman of the Board Comp: $5.48MMs. Cheung Ling Cheng (Age 60)Executive Vice Chairwoman of the Board Comp: $4.86MMs. Mingqin Li (Age 65)Senior VP & Executive Director Comp: $165.76kMr. Zhoushan Tian (Age 60)Executive Director Comp: $258.45kMr. Hsin Tse (Age 54)Senior VP & Executive Director Comp: $832.53kMr. Eric S. Y. Tse (Age 28)CEO & Executive Director Comp: $3.19MMr. Ping Tse (Age 72)Founder & Senior Executive Vice Chairman Comp: $5.79MMs. Chun Ling Li (Age 52)Chief Financial Officer Sean ChenChief Strategy OfficerOrphanides GeorgeChief Scientific Advisor of invoXMore ExecutivesKey CompetitorsAspen PharmacareOTCMKTS:APNHYSWEDISH ORPHAN/SOTCMKTS:SWTUYOrion OyjOTCMKTS:ORINYHikma PharmaceuticalsOTCMKTS:HKMPFZealand Pharma A/SOTCMKTS:ZLDPFView All Competitors SBMFF Stock Analysis - Frequently Asked Questions How have SBMFF shares performed in 2024? Sino Biopharmaceutical's stock was trading at $0.4157 at the beginning of 2024. Since then, SBMFF shares have decreased by 24.2% and is now trading at $0.3150. View the best growth stocks for 2024 here. Are investors shorting Sino Biopharmaceutical? Sino Biopharmaceutical saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 15,423,100 shares, an increase of 190.5% from the March 31st total of 5,308,700 shares. Based on an average daily trading volume, of 800 shares, the days-to-cover ratio is currently 19,278.9 days. View Sino Biopharmaceutical's Short Interest. How do I buy shares of Sino Biopharmaceutical? Shares of SBMFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:SBMFF) was last updated on 5/1/2024 by MarketBeat.com Staff From Our PartnersElon’s New Device is About to Shock the WorldInvestorPlace😱 This phenomenon is smashing regular market gainsMillPubYour bank is lying to you.MyBankTrackerDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersForget Nvidia. This is the future of AIPorter & CompanyBiden out June 13; Kamala won’t replace him?Paradigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sino Biopharmaceutical Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
